XLO
Xilio Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026
7.63USD+1.194%(+0.09)8,548
After-hoursNov 18, 2026 4:00:30 PM EST
7.63USD-2.242%(-0.17)
XLO Financials
In Q3 FY 2026 (ended ), Xilio Therapeutics, Inc. Common Stock (XLO) reported revenue of $9.98M, net income of −$5.95M, operating cash flow of −$13.79M, and assets of $134.83M (filed ).
Loading financial statements…